Cargando…
Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model
Progressive familial intrahepatic cholestasis type 3 (PFIC3) is a rare monogenic disease caused by mutations in the ABCB4 gene, resulting in a reduction in biliary phosphatidylcholine. Reduced biliary phosphatidylcholine cannot counteract the detergent effects of bile salts, leading to cholestasis,...
Autores principales: | Weber, Nicholas D., Odriozola, Leticia, Martínez-García, Javier, Ferrer, Veronica, Douar, Anne, Bénichou, Bernard, González-Aseguinolaza, Gloria, Smerdou, Cristian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910969/ https://www.ncbi.nlm.nih.gov/pubmed/31836711 http://dx.doi.org/10.1038/s41467-019-13614-3 |
Ejemplares similares
-
Gene Therapy for Acquired and Genetic Cholestasis
por: Martínez-García, Javier, et al.
Publicado: (2022) -
A minimal bile salt excretory pump promoter allows bile acid-driven physiological regulation of transgene expression from a gene therapy vector
por: Martínez-García, Javier, et al.
Publicado: (2022) -
Progressive familial intrahepatic cholestasis
por: Davit-Spraul, Anne, et al.
Publicado: (2009) -
Familial Intrahepatic Cholestasis: An Update
por: Riely, Caroline A.
Publicado: (1979) -
Liver Transplantation for Progressive Familial Intrahepatic Cholestasis
por: Liu, Ying, et al.
Publicado: (2018)